Divarasib + Inavolisib for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 29 Jun 2020: Trial registered, NCT04449874
  2. 29 Jul 2020: Trial started, NCT04449874

The trials

NCT04449874: A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

State
Under way
Phase
Phase 1
People
498 planned
Started
29 Jul 2020
Primary completion
31 Dec 2027
Arms
Arm G: GDC-6036 + Inavolisib (Stage I and Stage II)
Results
None posted
  1. 29 Jun 2020: Trial registered
  2. 29 Jul 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.